Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas

Survival from pancreatic cancer remains extremely poor, in part because this malignancy is not diagnosed in the early stages, and precancerous pancreatic intraepithelial neoplasia (PanIN) lesions are not seen on routine radiographic imaging. Since the cholecystokinin-B receptor (CCK-BR) becomes over...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jill P., Cao, Hong, Edmondson, Elijah F., Dasa, Siva Sai Krishna, Stern, Stephan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698999/
https://www.ncbi.nlm.nih.gov/pubmed/34944412
http://dx.doi.org/10.3390/biom11121766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698999/
https://www.ncbi.nlm.nih.gov/pubmed/34944412
http://dx.doi.org/10.3390/biom11121766

Ejemplares similares